Permitted daily exposure from preclinical studies of Ginkgo biloba L. dry extract
Braz. J. Pharm. Sci. (Online); 59 (), 2023
Abstract Resolution 658/2022 of the Brazilian Regulatory Agency requires the determination of the permitted daily exposure (PDE) of pharmaceutical agents. Ginkgo biloba L. is used therapeutically to treat memory deficits and other brain diseases. However, published results indicate that more studies are ...